These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 15953931)

  • 1. Evolution of antifungal-drug resistance: mechanisms and pathogen fitness.
    Anderson JB
    Nat Rev Microbiol; 2005 Jul; 3(7):547-56. PubMed ID: 15953931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population dynamics and the evolution of antifungal drug resistance in Candida albicans.
    Huang M; Kao KC
    FEMS Microbiol Lett; 2012 Aug; 333(2):85-93. PubMed ID: 22540673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation.
    Sanglard D; Coste A; Ferrari S
    FEMS Yeast Res; 2009 Oct; 9(7):1029-50. PubMed ID: 19799636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The evolution of fungal drug resistance: modulating the trajectory from genotype to phenotype.
    Cowen LE
    Nat Rev Microbiol; 2008 Mar; 6(3):187-98. PubMed ID: 18246082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of drug resistance in Candida albicans.
    Cowen LE; Anderson JB; Kohn LM
    Annu Rev Microbiol; 2002; 56():139-65. PubMed ID: 12142485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug susceptibilities of yeast cells are affected when expressing mutant Candida albicans drug resistance protein.
    Gao PH; Cao YB; Jia XM; Cao YY; Quan H; Wang Y; Jiang YY
    Int J Antimicrob Agents; 2006 Jul; 28(1):69-74. PubMed ID: 16782311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antifungal resistance in opportunistic pathogenic fungi (II). Imidazoles and triazoles].
    Martínez-Suárez JV; Rodríguez-Tudela JL
    Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):490-8. PubMed ID: 9011208
    [No Abstract]   [Full Text] [Related]  

  • 8. Mitochondria and fungal pathogenesis: drug tolerance, virulence, and potential for antifungal therapy.
    Shingu-Vazquez M; Traven A
    Eukaryot Cell; 2011 Nov; 10(11):1376-83. PubMed ID: 21926328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms influencing the evolution of resistance to Qo inhibitor fungicides.
    Gisi U; Sierotzki H; Cook A; McCaffery A
    Pest Manag Sci; 2002 Sep; 58(9):859-67. PubMed ID: 12233175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Biochemistry of azole derivatives and the problem of drug resistance].
    Kerridge D; Parker S
    Ann Dermatol Venereol; 1989; 116 Suppl 1():7-9. PubMed ID: 2688527
    [No Abstract]   [Full Text] [Related]  

  • 11. Rep1p negatively regulating MDR1 efflux pump involved in drug resistance in Candida albicans.
    Chen CG; Yang YL; Tseng KY; Shih HI; Liou CH; Lin CC; Lo HJ
    Fungal Genet Biol; 2009 Sep; 46(9):714-20. PubMed ID: 19527793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Evolution of Antifungal Drug Resistance.
    Robbins N; Caplan T; Cowen LE
    Annu Rev Microbiol; 2017 Sep; 71():753-775. PubMed ID: 28886681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The genetics of medically important fungi.
    Whelan WL
    Crit Rev Microbiol; 1987; 14(2):99-170. PubMed ID: 3549159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of uracil-based histone deacetylase inhibitors able to reduce acquired antifungal resistance and trailing growth in Candida albicans.
    Mai A; Rotili D; Massa S; Brosch G; Simonetti G; Passariello C; Palamara AT
    Bioorg Med Chem Lett; 2007 Mar; 17(5):1221-5. PubMed ID: 17196388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell biology. A fungal Achilles' heel.
    Heitman J
    Science; 2005 Sep; 309(5744):2175-6. PubMed ID: 16195450
    [No Abstract]   [Full Text] [Related]  

  • 16. Two mutants selectively resistant to polyenes reveal distinct mechanisms of antifungal activity by nystatin and amphotericin B.
    Hapala I; Klobucníková V; Mazánová K; Kohút P
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1206-9. PubMed ID: 16246082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting virulence: a new paradigm for antifungals.
    Gauwerky K; Borelli C; Korting HC
    Drug Discov Today; 2009 Feb; 14(3-4):214-22. PubMed ID: 19152839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The comparison of susceptibility of Candida albicans and Candida glabrata to miconazole].
    Kurnatowski P; Makieło L; Horwatt-Bozyczko E
    Wiad Parazytol; 2001; 47(4):867-73. PubMed ID: 16886440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and fungicidal activity of 3,5-dichloropyrazin-2(1H)-one derivatives.
    François IE; Cammue BP; Bresseleers S; Fleuren H; Hoornaert G; Mehta VP; Modha SG; Van der Eycken EV; Thevissen K
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4064-6. PubMed ID: 19556127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fungal resistance in Cambodian children with acquired immunodeficiency syndrome.
    Krcmery V; Augustinova A; Babelova O; Doczeova A; Liskova A
    Pediatr Infect Dis J; 2006 May; 25(5):470. PubMed ID: 16645523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.